Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127609511 | 12760951 | 1 | I | 20160911 | 20160919 | 20160919 | EXP | US-ASTRAZENECA-2016SE97276 | ASTRAZENECA | 0.00 | F | Y | 141.10000 | KG | 20160920 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127609511 | 12760951 | 1 | PS | BYETTA | EXENATIDE | 1 | Subcutaneous | C097007A | 21773 | 10 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | ||||||
| 127609511 | 12760951 | 2 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | 10 | 21773 | SOLUTION FOR INJECTION IN PRE-FILLED PEN | |||||||||
| 127609511 | 12760951 | 3 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 10.0MG UNKNOWN | U | U | 0 | 10 | MG | TABLET | |||||
| 127609511 | 12760951 | 4 | C | ACTOS | PIOGLITAZONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127609511 | 12760951 | 5 | C | VITAMINS | VITAMINS | 1 | 0 | ||||||||||||
| 127609511 | 12760951 | 6 | C | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | 0 | ||||||||||||
| 127609511 | 12760951 | 7 | C | GLUMETZA | METFORMIN HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127609511 | 12760951 | 1 | Type 2 diabetes mellitus |
| 127609511 | 12760951 | 2 | Type 2 diabetes mellitus |
| 127609511 | 12760951 | 3 | Type 2 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127609511 | 12760951 | DS |
| 127609511 | 12760951 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127609511 | 12760951 | Blood glucose fluctuation | |
| 127609511 | 12760951 | Blood glucose increased | |
| 127609511 | 12760951 | Body height decreased | |
| 127609511 | 12760951 | Carpal tunnel syndrome | |
| 127609511 | 12760951 | Decreased appetite | |
| 127609511 | 12760951 | Fatigue | |
| 127609511 | 12760951 | Lymphoedema | |
| 127609511 | 12760951 | Muscle spasms | |
| 127609511 | 12760951 | Musculoskeletal stiffness | |
| 127609511 | 12760951 | Nerve injury | |
| 127609511 | 12760951 | Pain | |
| 127609511 | 12760951 | Peripheral swelling | |
| 127609511 | 12760951 | Rectal cancer | |
| 127609511 | 12760951 | Skin ulcer | |
| 127609511 | 12760951 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127609511 | 12760951 | 3 | 2004 | 0 |